Valeritas
Valeritas designs, manufactures and distributes insulin delivery devices for diabetic patients.
Business Model:
Revenue: $29.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Valeritas Information
Valeritas was acquired by
Zealand Pharma.
The acquisition happend on 2020-02-10.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 750 Route 202 South
City: Bridgewater
State: NJ
Zip: 08807
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$334M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Valeritas designs, manufactures and distributes insulin delivery devices for diabetic patients.
Contact Phone:
+19089279920
Contact Email:
Valeritas went public on 3/23/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/23/2017
IPO Valuation:
$69M
Ticker Symbol:
VLRX
IPO Price:
$10/share
Amount Raised:
$53M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
